Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Sales | 109,456 | 101,614 | 97,750 | 91,950 | 84,953 |
| Cost of Goods | 20,796 | 20,469 | 18,003 | 14,401 | 17,412 |
| Gross Profit | 88,660 | 81,145 | 79,747 | 77,549 | 67,541 |
| Operating Expenses | 87,162 | 84,964 | 81,689 | 74,907 | 65,163 |
| Operating Income | 2,294 | -3,350 | -1,939 | 3,043 | 2,790 |
| Interest Expense | 2,163 | 2,746 | 3,008 | 2,635 | 2,429 |
| Other Income | 262 | -13,142 | 329 | 171 | 1,426 |
| Pre-tax Income | 393 | -19,238 | -4,618 | 579 | 1,787 |
| Income Tax | 4,764 | -7,049 | -221,952 | 1,056 | 636 |
| Net Income Continuous | -4,371 | -12,189 | 217,334 | -477 | 1,151 |
| Net Income | $-4,371 | $-12,189 | $217,334 | $-477 | $1,151 |
| EPS Basic Total Ops | -0.04 | -0.14 | 2.13 | 0.00 | 0.01 |
| EPS Basic Continuous Ops | -0.04 | -0.14 | 2.13 | 0.00 | 0.01 |
| EPS Diluted Total Ops | -0.04 | 0.05 | 1.68 | -0.01 | 0.01 |
| EPS Diluted Continuous Ops | -0.04 | -0.02 | 1.66 | 0.00 | 0.01 |
| EBITDA(a) | $11,959 | $5,528 | $6,885 | $10,923 | $9,398 |